Preparation method of recombinant adeno-associated virus expressing hsa-miR-21<*> and application in treatment of hypertension
A technology of hsa-mir-21 and anti-hsa-mir-21, which is applied in the preparation of recombinant adeno-associated virus expressing hsa-miR-21* and its application in the treatment of hypertension, can solve the problem of unsuitable Clinical application, short expression time of adenovirus vector, and worrying about biological safety, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Example 1 Screening of aortic miRNA expression in spontaneously hypertensive rats
[0024] 1. In this experiment, 4-week-old spontaneously hypertensive rats (SHR) and control rats (Wistar) were used, fed for 8 weeks, and the blood pressure of the tail artery of the rats was monitored. The results showed that the basal blood pressure of SHR was significantly higher than that of normal control rats, and as the week age increased, the blood pressure level of SHR rats continued to rise ( Figure 1A ).
[0025] 2. At the end of the experiment (week), the rat aortic RNA was routinely extracted:
[0026] Add 1ml TRIZOL reagent per 100mg of tissue, and homogenize with an electric homogenizer. After standing at room temperature for 5 minutes, add 0.2ml of chloroform, mix well, leave at room temperature for 5 minutes, and centrifuge at 12,000g at 4°C for 15 minutes. Transfer the upper aqueous phase to a new Ep tube, add 0.5ml of isopropanol, mix well, place at room temperature fo...
Embodiment 2
[0057] Example 2 Construction of recombinant adeno-associated virus
[0058] 1. Insert synthesis
[0059] Based on hsa-miR-21 * base sequence ( figure 2 ), respectively designed and synthesized to express hsa-miR-21 * and reverse complementary hsa-anti-miR-21 * The two reverse complementary strands were dissolved with TE. The sequence is as follows:
[0060] hsa-miR-21 * :
[0061] Upstream primer: 5'GATCCacagcccatcgactggtgttgTTCAAGAGAcaacaccagtcgatgggctgtCCGC 3'
[0062] Downstream primer: 3'GtgtcgggtagctgaccacaacAAGTTCTCTgttgtggtcagctacccgacaGGCGCCGG 5'
[0063] hsa-anti-miR-21 * :
[0064] Upstream primer: 5'GATCCcaacaccagtcgatgggctgtTTCAAGAGAacagcccatcgactggtgttgCCGC 3'
[0065] Downstream primer: 3'GgttgtggtcagctacccgacaAAGTTCTCTtgtcgggtagctgaccacaacGGCGCCGG 5'
[0066] 2. Carry out the reaction according to the system and temperature in the instructions:
[0067] Nuclease-Free Water 36μl
[0068] Annealing Buffer for DNA Oligos (5X) 10μl
[0069] DNA olig...
Embodiment 3
[0155] Example 3 Expression of hsa-miR-21 *The therapeutic effect of recombinant adeno-associated virus on hypertension
[0156] 1. SHR rat aorta miR-21 * Expression detection:
[0157] We used 4-week-old SHR rats and injected rAAV-miR-21 through the tail vein respectively. * and rAAV-anti-miR-21 * , virus titer 1×10 11 PFU / per rat, at the end of the experiment (after 8 weeks), real-time PCR was used to detect miR-21 in the aorta of SHR rats * The expression of rAAV-miR-21 * Treatment can significantly increase aortic miR-21 * The expression of rAAV-anti-miR-21 * Treatment can significantly reduce aortic miR-21 * expression( Figure 5 ).
[0158] 2. SHR rat blood pressure monitoring:
[0159] Tail artery blood pressure was measured every 2 weeks, and the results showed that: rAAV-miR-21 * Treatment can significantly reduce the systolic blood pressure level of SHR rats in a time-dependent manner, while rAAV-anti-miR-21 * The treatment can significantly increase the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com